Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
PharmaLex Group has added Sébastien Schmitt to the company’s senior management team.
read more
Tuesday, December 29, 2015
Roughly half of all surveyed global and U.S. pharmaceutical teams report involving key opinion leader (KOL) management or medical science liaison (MSL) teams in their investigator-initiated trial (IIT) proposal collection processes.
read more
Thursday, January 14, 2016
Pharm-Olam International Ltd., a clinical research solutions organization to the biopharmaceutical and medical device industries, has announced its expansion of Phase I-IV clinical trial services into the Asia-Pacific region.
read more
Made Scientific announced a significant expansion of its Princeton, New Jersey facility to meet increasing demand from late-phase and commercial clients and support the anticipated rise in approved advanced therapies.
read more
Friday, November 09, 2018
The UK BioIndustry Association has been granted permission by the UK Supreme Court to intervene in a case that could have far-reaching impacts on the life sciences sector.
read more
Thursday, October 24, 2013
Norwich Pharmaceuticals, a provider of full-service contract development and manufacturing services for the pharmaceutical and biotech industry, today announced that it has changed its name to Norwich Pharma Services. The new name and brand identity ...
read more
Hovione and Zerion Pharma A/S revealed an extension of their collaboration on Zerion's Dispersome® technology into the nutraceutical/diet supplements domain. Many dietary supplements suffer from low solubility.
read more
IQVIA and Genomics England announced a collaboration to develop a platform that will connect clinical and de-identified genomics data to accelerate treatment advancements for patients.
read more
Thursday, December 20, 2018
Recipharm announced that it will explore the discontinuance of operations at its solid dose manufacturing facility in Ashton-under-Lyne, UK.
read more
Monday, September 19, 2016
PAREXEL International Corporation a global biopharmaceutical services organization, has announced the appointment of Christian Dreger, Ph.D., as Senior Vice President, PAREXEL Access and PAREXEL Consulting.
read more
Bristol-Myers Squibb Company has announced that the U.S. Food and Drug Administration (FDA) has approved Opdivo (nivolumab) in combination with Yervoy (ipilimumab) for the treatment of patients with BRAF V600 wild-type and BRAF V600 mutation-positive...
read more
Oxford Biomedica announced the UK MHRA has issued a Certificate of GMP compliance for the fourth GMP manufacturing suite within the Group’s new Oxbox manufacturing facility.
read more
apceth Biopharma GmbH will operate as the commercial manufacturer in Europe for Zynteglo™, a product of bluebird bio.
read more
Medidata a global provider of cloud-based solutions for clinical research, has signed a multi-year enterprise deal with Hanmi Pharmaceutical, one of South Korea's leading drug makers.
read more
Wednesday, October 07, 2020
MCRA has announced its role in the successful management and execution of Simplify Medical's clinical study and approval by the FDA of their PMA for the Simplify Disc.
read more